Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

10Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: Irisin is a unique myokine with striking effects on regulating insulin sensitivity and energy metabolism. This study aimed to investigate the changes in serum irisin in patients with newly diagnosed type 2 diabetes mellitus (T2DM) following sitagliptin treatment. Methods: Thirty-two patients with T2DM were treated with 100 mg/day sitagliptin for 16 weeks. Twenty age-, sex- and body mass index (BMI)-matched healthy subjects were enrolled as the control group. Irisin and metabolic parameters were measured at baseline and after treatment. Results: Patients with T2DM had lower irisin levels than the controls (10.03 ± 2.06 vs. 13.06 ± 3.10 ng/ml, P < 0.01). Sitagliptin treatment significantly increased serum irisin levels in T2DM patients compared to baseline (11.18 ± 1.91 vs. 10.03 ± 2.06 ng/ml, P < 0.01). Increased irisin levels were associated with decreased fasting blood glucose (FBG) (β = − 0.24, P < 0.05) and glycosylated hemoglobin (HbA1c) (β = − 0.15, P < 0.05). Conclusions: Sitagliptin treatment significantly increased serum irisin levels in patients with T2DM, and the increase of the irisin level was associated with decreases of FBG and HbA1c levels. These results suggest that irisin might be involved in the antidiabetic mechanisms of sitagliptin. Trial Registration: ClinicalTrials.gov identifier NCT04495881.

References Powered by Scopus

Standards of medical care in diabetes-2014

0
3939Citations
N/AReaders
Get full text

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

3888Citations
N/AReaders
Get full text

Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

3842Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Irisin alleviates high glucose-induced hypertrophy in H9c2 cardiomyoblasts by inhibiting endoplasmic reticulum stress

8Citations
N/AReaders
Get full text

One hundred years since insulin discovery: An update on current and future perspectives for pharmacotherapy of diabetes mellitus

8Citations
N/AReaders
Get full text

Sitagliptin Attenuates the Cognitive Deficits in L-Methionine-Induced Vascular Dementia in Rats

8Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wang, Q., Ma, L., Zhang, Y., Zhang, L., An, Y., Liu, J., & Wang, G. (2021). Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes Therapy, 12(4), 1029–1039. https://doi.org/10.1007/s13300-021-01023-z

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

83%

Researcher 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

57%

Pharmacology, Toxicology and Pharmaceut... 2

29%

Agricultural and Biological Sciences 1

14%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free